Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chemotherapy-induced Anaemia”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableStudy completedNCT01807091
What this trial is testing

Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
Adult Acute Myeloid LeukemiaAdult Myelodysplastic Syndrome
University of Washington 17
Not applicableStudy completedNCT07790692
What this trial is testing

Efficacy and Safety of Heated Chinese Herb Medicine Patch Therapy on Chemotherapy-Induced Aplastic Anemia

Who this might be right for
CancerAnemia
Hung-Rong Yen 40
Large-scale testing (Phase 3)Ended earlyNCT04607668
What this trial is testing

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC):

Who this might be right for
Colorectal Cancer MetastaticMyelosuppression-AdultChemotherapeutic Toxicity
G1 Therapeutics, Inc. 326
Large-scale testing (Phase 3)UnknownNCT05768997
What this trial is testing

High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia

Who this might be right for
Anemia
Hallym University Medical Center 312
Testing effectiveness (Phase 2)Ended earlyNCT03593915
What this trial is testing

A Phase 1b/2 Study of Alvocidib Plus Decitabine or Azacitidine in Patients With MDS

Who this might be right for
Myelodysplastic Syndromes (MDS)
Sumitomo Pharma America, Inc. 20
Large-scale testing (Phase 3)UnknownNCT05704894
What this trial is testing

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Who this might be right for
AnemiaNeoplasmsChemotherapeutic-Induced Anemia
Blau Farmaceutica S.A. 320
Testing effectiveness (Phase 2)Study completedNCT00239239
What this trial is testing

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

Who this might be right for
Non-Myeloid MalignanciesAnemiaCancer
Amgen 44
Testing effectiveness (Phase 2)Study completedNCT00401544
What this trial is testing

Darbepoetin Alfa With or Without Intravenous (IV) Iron

Who this might be right for
AnemiaNon-Myeloid Malignancies
Amgen 243
Testing effectiveness (Phase 2)Study completedNCT00005942
What this trial is testing

Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy

Who this might be right for
Chronic Myelomonocytic LeukemiaPreviously Treated Myelodysplastic SyndromesRecurrent Adult Acute Myeloid Leukemia+2 more
National Cancer Institute (NCI) 37
Post-approval studies (Phase 4)Study completedNCT00315484
What this trial is testing

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

Who this might be right for
AnemiaChemotherapy
Ortho Biotech Products, L.P. 358
Testing effectiveness (Phase 2)Ended earlyNCT01284348
What this trial is testing

To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
AnemiaCarcinoma, Non-Small-Cell LungCarcinoma, Small-Cell Lung+3 more
Merck Sharp & Dohme LLC 26
Large-scale testing (Phase 3)Study completedNCT02767765
What this trial is testing

Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

Who this might be right for
Anemia
Hoffmann-La Roche 61
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06737081
What this trial is testing

SAL-0951 in the Treatment of Chemotherapy-induced Anemia in Patients With Non-myeloid Malignancies

Who this might be right for
Anemia
Shenzhen Salubris Pharmaceuticals Co., Ltd. 60
Not applicableStudy completedNCT00212862
What this trial is testing

Dosing and Outcomes Study of Erythropoietic Stimulating Therapies in Patients With Chemotherapy Induced Anemia

Who this might be right for
AnemiaCancer
Ortho Biotech Products, L.P. 2,130
Large-scale testing (Phase 3)Study completedNCT00002517
What this trial is testing

Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
European Organisation for Research and Treatment of Cancer - EORTC
Testing effectiveness (Phase 2)UnknownNCT02781155
What this trial is testing

Limiting Chemotherapy Side Effects by Using Moxa

Who this might be right for
Breast NeoplasmsColorectal NeoplasmsGenital Neoplasms, Female+1 more
East and North Hertfordshire NHS Trust 25
Early research (Phase 1)Study completedNCT01280240
What this trial is testing

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

Who this might be right for
Patients With Chemotherapy Induced Anemia (CIA)
Pharmacosmos A/S 11
Not applicableUnknownNCT02860598
What this trial is testing

Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy

Who this might be right for
AnemiaAcute Myeloid Leukemia
Hospices Civils de Lyon 104
Testing effectiveness (Phase 2)Ended earlyNCT00210002
What this trial is testing

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

Who this might be right for
NeoplasmsAnemia
Institut Claudius Regaud 55
Next Page